ResMed Inc. (RMD) earnings: date, estimates, results and stock reactions
Next earnings: Q2 FY2027 on 2027-01-28 (expected, after the close). EPS estimate 3.03, revenue estimate 1.46B.
Over the last 12 reports the stock moved 6.3% on average (either way), rising 7 times and falling 5. EPS beat estimates 11 of 12 times; revenue 12 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 2026-10-29 | 2.91 | 2.69 | +8.2% | 1.41B | 1.39B | -8.1% |
| Q4 FY2026 | 2026-08-06 | 2.95 | 2.89 | +2.1% | 1.46B | 1.46B | -5.4% |
| Q3 FY2026 | 2026-04-30 | 2.86 | 2.80 | +2.1% | 1.43B | 1.42B | -3.3% |
| Q2 FY2026 | 2026-01-29 | 2.81 | 2.74 | +2.6% | 1.42B | 1.40B | +0.2% |
| Q1 FY2026 | 2025-10-30 | 2.55 | 2.51 | +1.6% | 1.34B | 1.33B | -2.7% |
| Q4 FY2025 | 2025-07-31 | 2.55 | 2.46 | +3.7% | 1.35B | 1.33B | +0.6% |
| Q3 FY2025 | 2025-04-23 | 2.37 | 2.38 | -0.4% | 1.29B | 1.29B | +10.3% |
| Q2 FY2025 | 2025-01-30 | 2.43 | 2.32 | +4.7% | 1.28B | 1.27B | -6.6% |